Stock BIO BIO-RAD LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Real-time Estimate Cboe BZX
Other stock markets
 02:20:44 2024-04-29 pm EDT 		5-day change 1st Jan Change
279.4 USD +1.24% Intraday chart for Bio-Rad Laboratories, Inc. -0.35% -13.54%
03:41pm RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474 MT
Apr. 26 Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bio-Rad Announces Life Science Group Management Changes
AQ
Bio-Rad Announces Life Science Group Management Changes
BU
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
BU
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
AQ
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
AQ
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
BU
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
BU
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
BU
Bio-Rad: Q4 Earnings Snapshot
AQ
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
BU
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
BU
Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference
AQ
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
BU
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
AQ
Bio-Rad: Q3 Earnings Snapshot
AQ
Bio-Rad Reports Third-Quarter 2023 Financial Results
BU
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
BU
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
BU
Bio-Rad Reports Second-Quarter 2023 Financial Results
BU
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIO Stock
  4. News Bio-Rad Laboratories, Inc.
  5. Press Releases